FDA.reportPublic FDA data

BIVALIRUDIN

Substance profile for UNII TN9BEX005G, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
TN9BEX005G
Preferred term
BIVALIRUDIN
Registry number
128270-60-0
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
60819
PubChem
0
NCIt
C47415
INN ID
7282

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm60819mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=60819
NCI ThesaurusC47415ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47415
FDA Substance Registration SystemTN9BEX005Gprecision.fda.gov/uniisearch/srs/unii/TN9BEX005G

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY]16
ACTIVE MOIETYANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY]16
ACTIVE INGREDIENTBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]2
ACTIVE MOIETYBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]2
ACTIVE MOIETYANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH]1
ACTIVE INGREDIENTANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH]1
ACTIVE INGREDIENTBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]1
ACTIVE MOIETYBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]1
ACTIVE MOIETYBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ]1
ACTIVE INGREDIENTBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ]1
ACTIVE MOIETYBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ]1
ACTIVE INGREDIENTBIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ]1